Desjardins Global Asset Management Inc. Bio Rad Laboratories, Inc. Transaction History
Desjardins Global Asset Management Inc.
- $922 Million
- Q4 2023
A detailed history of Desjardins Global Asset Management Inc. transactions in Bio Rad Laboratories, Inc. stock. As of the latest transaction made, Desjardins Global Asset Management Inc. holds 77 shares of BIO stock, worth $23,262. This represents 0.0% of its overall portfolio holdings.
Number of Shares
77
Previous 75
2.67%
Holding current value
$23,262
Previous $26,000
7.69%
% of portfolio
0.0%
Previous 0.0%
Shares
7 transactions
Others Institutions Holding BIO
# of Institutions
490Shares Held
17.8MCall Options Held
44.9KPut Options Held
79.7K-
Vanguard Group Inc Valley Forge, PA2.42MShares$732 Million0.02% of portfolio
-
Black Rock Inc. New York, NY1.48MShares$447 Million0.01% of portfolio
-
Veritas Asset Management LLP1.15MShares$347 Million3.33% of portfolio
-
State Street Corp Boston, MA874KShares$264 Million0.01% of portfolio
-
Earnest Partners LLC Atlanta, GA515KShares$156 Million0.84% of portfolio
About BIO-RAD LABORATORIES, INC.
- Ticker BIO
- Exchange NYSE
- Sector Healthcare
- Industry Medical Devices
- Shares Outstandng 24,633,900
- Market Cap $7.44B
- Description
- Bio-Rad Laboratories, Inc. manufactures, and distributes life science research and clinical diagnostic products in the United States, Europe, Asia, Canada, and Latin America. The company operates through Life Science and Clinical Diagnostics segments. The Life Science segment develops, manufactures, and markets a range of reagents, apparatus, an...